Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

Acne Vulgaris Clinical Trial

Official title:

Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02905851
• Other study ID #: 869597
• Status: Completed
• Phase: N/A
• Start date: May 2016
• Est. completion date: May 2018

Study information

• Verified date: June 2018
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris

Description:

The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use.

There are two arms of the study:

1. Feedback group

2. Non feedback group

All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months).

The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4
• Est. completion date: May 2018
• Est. primary completion date: May 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• Subjects aged 15 years and older

• Subjects who have been prescribed doxycycline or minocycline by their physician for acne vulgaris but have not initiated treatment yet.

Exclusion Criteria:

• Subjects who have used isotretinoin in the last 6 weeks

• Those who have used oral antibiotics within the last 4 weeks

• Those who have been initiated or changed brand of oral contraceptive pill within the last one month.

• Those subjects who cannot engage with the teledermatology platform

• Prisoners

• Adults unable to consent

Related Conditions & MeSH terms

• Acne Vulgaris

Intervention

Other:
• Feedback group
Monitoring ability to use teledermatology to modify antibiotic burden
• Non Feedback group
To use as control to see if antibiotic burden has been reduced in the active feedback group

Locations

Country	Name	City	State
United States	UC Davis Department of Dermatology, Clinical Trials Unit	Sacramento	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Change in acne grading (change in patient grading)	Change in Patient Grading	Assessed at 4, 8, 12 weeks
Other	Change in acne grading (investigator global assessment)	Change in Investigator Global Assessment	Assessed at 4, 8, 12 weeks
Other	Change in acne grading (lesion counting)	Change in Lesion Counting	Assessed at 4, 8, 12 weeks
Other	Change in acne grading using the global acne grading	Change in Global Acne Grading	Assessed at 4, 8, 12 weeks
Primary	Reduced antibiotic use	The difference in antibiotic exposure in the physician feedback group compared to those not receiving feedback	Assessed at 4, 8, 12 weeks